Prestige Consumer Healthcare (PBH) reported fiscal Q4 adjusted earnings late Wednesday of $1.23 per diluted share, down from $1.32 a year earlier.
Analysts surveyed by FactSet expected $1.39.
Revenue for the quarter ended March 31 was $281.6 million, down from $296.5 million a year earlier.
Analysts polled by FactSet expected $293.6 million.
The company expects fiscal 2027 adjusted EPS of $4.42 to $4.51 on revenue of $1.10 billion to $1.12 billion. Analysts expect $4.79 and $1.16 billion, respectively.
Also, the company said it agreed to acquire Australia-based LaCorium Health, a therapeutic skin care provider designed to treat individual skin ailments, for about $150 million in cash. The transaction, subject to customary conditions, is expected to close in Q2, it added.